State of New Jersey Common Pension Fund D Has $7.82 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

State of New Jersey Common Pension Fund D decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 34.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 26,584 shares of the biotechnology company’s stock after selling 14,044 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Axon Enterprise were worth $7,822,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of AXON. ICA Group Wealth Management LLC acquired a new stake in Axon Enterprise in the 4th quarter worth about $26,000. Blue Trust Inc. raised its stake in Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares in the last quarter. Trivant Custom Portfolio Group LLC acquired a new stake in Axon Enterprise in the 1st quarter worth about $31,000. First PREMIER Bank bought a new position in Axon Enterprise in the 1st quarter valued at about $33,000. Finally, Blue Bell Private Wealth Management LLC bought a new position in Axon Enterprise in the 1st quarter valued at about $41,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Down 1.3 %

AXON opened at $379.61 on Friday. Axon Enterprise, Inc. has a fifty-two week low of $189.12 and a fifty-two week high of $385.00. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. The firm has a market capitalization of $28.69 billion, a price-to-earnings ratio of 111.00, a PEG ratio of 10.30 and a beta of 0.94. The company’s 50 day moving average price is $338.92 and its two-hundred day moving average price is $314.65.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The firm had revenue of $504.00 million for the quarter, compared to analyst estimates of $478.35 million. During the same period in the previous year, the firm posted $0.80 EPS. The company’s revenue for the quarter was up 34.5% compared to the same quarter last year. As a group, research analysts predict that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In other news, Director Matthew R. Mcbrady sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the transaction, the director now owns 4,892 shares in the company, valued at approximately $1,783,916.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Matthew R. Mcbrady sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the transaction, the director now owns 4,892 shares in the company, valued at approximately $1,783,916.72. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 316,981 shares of company stock worth $115,281,744. Company insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on AXON. Craig Hallum raised their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Jefferies Financial Group began coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price on the stock. JMP Securities raised their target price on shares of Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday. Barclays raised their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $365.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.